The White House will soon move to rapidly repeal or freeze rules that affect health, food, workplace safety, transportation and more.
Category: Regulation and Deregulation of Industry
-
How the Crypto Industry’s Political Spending Is Paying Off
Federal lawmakers who benefited from crypto largess in the 2024 election are speedily advancing the industry’s agenda.
-
RFK Jr. Accuses FDA of Drug Industry Influence That Barred Alternative Remedies
The nation’s health secretary addressed agency employees, asking them to shed any corporate influence. But he did not address the mass layoffs that have gutted oversight of tobacco and vapes, food safety and drug reviews.
-
Medicare Bleeds Billions on Pricey Bandages, and Doctors Get a Cut
Medicare spending on “skin substitutes” made of dried placenta has soared as doctors pocket lucrative discounts from sellers.
-
House Strikes Down $5 Overdraft Fee Limit, Sending Issue to Trump
Lawmakers also struck down a rule giving the Consumer Financial Protection Bureau supervisory power over tech companies’ payments apps.
-
Small Businesses Face a ‘Tornado’ of Challenges: Cuts, Freezes and Now Tariffs
President Trump vowed to aid entrepreneurs by reducing taxes and slicing red tape. But some owners say other policies have put them at a disadvantage.
-
Powell Warns Trump’s Tariffs Risk Stoking Even Higher Inflation and Slower Growth
Jerome H. Powell, chair of the Federal Reserve, says the central bank’s “obligation” is to ensure that a “one-time increase in the price level does not become an ongoing inflation problem.”
-
Trump’s Next Tariffs Target Could be Foreign-Made Pharmaceuticals
President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result in shortages and higher prices for generic drugs.
-
FDA Layoffs Could Raise Drug Costs and Erode Food Safety
Trump cutbacks were supposedly aimed at administrators. But scientists in food and drug-testing labs and policy experts who advance generic drug approvals were also dismissed.
-
Capital One Deal for Discover Clears Justice Dept. Hurdle
The department, during the Biden administration, initially said it had concerns about the merger of two of the largest credit card companies in the U.S.